These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31521729)
61. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004 [TBL] [Abstract][Full Text] [Related]
62. Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate. Lim DK; Porter AB; Hoskins B; Ho IK Toxicol Appl Pharmacol; 1987 Sep; 90(3):477-89. PubMed ID: 3660414 [TBL] [Abstract][Full Text] [Related]
63. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. Nichols RH; Chambers JE Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259 [TBL] [Abstract][Full Text] [Related]
64. Cold exposure decreases the effectiveness of atropine-oxime treatment in organophosphate intoxication in rats and mice. Kaliste-Korhonen E; Ryhänen R; Ylitalo P; Hänninen O Gen Pharmacol; 1989; 20(6):805-9. PubMed ID: 2687080 [TBL] [Abstract][Full Text] [Related]
66. Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity. Tuovinen K; Kaliste-Korhonen E; Hänninen O Gen Pharmacol; 1997 Sep; 29(3):333-5. PubMed ID: 9378236 [TBL] [Abstract][Full Text] [Related]
67. Mechanisms involved in the development of tolerance to DFP toxicity. Gupta RC; Patterson GT; Dettbarn WD Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885 [TBL] [Abstract][Full Text] [Related]
69. Factors influencing diisopropyl fluorophosphate-induced hypothermia and hyperthermia in the rat. Gordon CJ Neurotoxicol Teratol; 1995; 17(6):679-83. PubMed ID: 8747750 [TBL] [Abstract][Full Text] [Related]
70. Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo. Yang ZP; Morrow J; Wu A; Roberts LJ; Dettbarn WD Biochem Pharmacol; 1996 Jul; 52(2):357-61. PubMed ID: 8694861 [TBL] [Abstract][Full Text] [Related]
71. Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae. Sánchez-Fortún S; Barahona MV Ecotoxicol Environ Saf; 2009 Mar; 72(3):775-80. PubMed ID: 18191451 [TBL] [Abstract][Full Text] [Related]
72. A single dose of the organophosphate triazophos induces fear extinction deficits accompanied by hippocampal acetylcholinesterase inhibition. Rodrigues JVF; Vidigal APP; Minassa VS; Batista TJ; de Lima RMS; Funck VR; Antero LS; Resstel LBM; Coitinho JB; Bertoglio LJ; Sampaio KN; Beijamini V Neurotoxicol Teratol; 2020; 82():106929. PubMed ID: 33031921 [TBL] [Abstract][Full Text] [Related]
73. Effects of polyhydroxyfullerenes on organophosphate-induced toxicity in mice. Ehrich M; Hinckley J; Werre SR; Zhou Z Toxicology; 2020 Dec; 445():152586. PubMed ID: 32949634 [TBL] [Abstract][Full Text] [Related]
74. In vitro age-related differences in rats to organophosphates. Meek EC; Carr RL; Chambers JE Toxicol In Vitro; 2021 Apr; 72():105102. PubMed ID: 33497710 [TBL] [Abstract][Full Text] [Related]
75. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Moser VC Neurotoxicol Teratol; 1995; 17(6):617-25. PubMed ID: 8747743 [TBL] [Abstract][Full Text] [Related]
76. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Chapman S; Kadar T; Gilat E Neurotoxicology; 2006 Mar; 27(2):277-83. PubMed ID: 16406030 [TBL] [Abstract][Full Text] [Related]
78. Corticosterone primes the neuroinflammatory response to Gulf War Illness-relevant organophosphates independently of acetylcholinesterase inhibition. Locker AR; Michalovicz LT; Kelly KA; Miller JV; Miller DB; O'Callaghan JP J Neurochem; 2017 Aug; 142(3):444-455. PubMed ID: 28500787 [TBL] [Abstract][Full Text] [Related]
79. Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase. Coban A; Carr RL; Chambers HW; Willeford KO; Chambers JE Toxicol Lett; 2016 Apr; 248():39-45. PubMed ID: 26965078 [TBL] [Abstract][Full Text] [Related]
80. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters. Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]